ARTICLE | Distillery Therapeutics
Hepatic
January 4, 2018 1:20 AM UTC
Patient sample, mouse and monkey studies suggest promoting TNFAIP3 expression could help treat NASH. In patient liver samples and mouse or cynomolgus monkey models of NASH, levels of TNFAIP3 were lowe...
BCIQ Company Profiles
BCIQ Target Profiles
Tumor necrosis factor (TNF) alpha-induced protein 3 (TNFAIP3) (A20)